DNAtriX Company
.jpg)
DNAtriX is a biotechnology company developing an oncolytic virus platform for treating malignant glioma.
Total Funding:
$57 084 013
Last Funding Date:
2018-09-12
Estimated Revenue:
$500M to $1B
Founded Date:
2005-01-01
Industry:
Women Cancer Treatment
Headquarters:
Houston, Texas, United States
Last Funding Type:
Venture - Series Unknown